Scientists say Ebola is no longer an incurable disease - after a trial of two drugs in the Democratic Republic of Congo put survival rates at 90 percent.
Four experimental drugs were used in an unprecedented clinical trial in the DRC, where Ebola has killed nearly 1,900 people over the past year.
Two of the drugs - Regeneron's REGN-EB3 and a monoclonal antibody called mAb114 - were developed using antibodies harvested from Ebola survivors.
Here's some good news: Doctors and scientists have finally found a way to cure Ebola. Here's how it works
The 90 percent survival rate was for people who received the drugs shortly after being infected, when levels of the virus in their blood were low.
Researchers are to make the treatments available to anyone in the DRC infected with the virus.
The trial's co-sponsor, the US National Institute of Allergy and Infectious Diseases, said the results were "very good news".
Read or Listen to this story on the RFI website.
Ebola Drugs 'Saving Lives' After Clinical Trials
AllAfrica publishes around 600 reports a day from more than 150 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.
Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.
AllAfrica is a voice of, by and about Africa - aggregating, producing and distributing 600 news and information items daily from over 150 African news organizations and our own reporters to an African and global public. We operate from Cape Town, Dakar, Abuja, Monrovia, Nairobi and Washington DC.